Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2435-2443

  Salloum, E ^a   Doria, R ^a   Schubert, W ^a   Zelterman, D ^a   Holford, T ^a   Roberts, K B ^a   Farber, L R ^a   Kiehl, R K ^a   Cardinale, J ^a   Cooper, D L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CARCINOGENESIS; FEMALE; HODGKIN DISEASE; HUMAN; LOW ENERGY RADIATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SECOND CANCER; SOLID TUMOR;

EID: 9544247712     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2435     Document Type: Article

References (41)

1. Valagussa P, Santoro A, Fossati BF, et al: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986
2. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
3. Tucker MA, Coleman CN, Cox RS, et al: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81, 1988
4. Swerdlow AJ, Douglas AJ, Hudson GV, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J 304:1137-1143, 1992
5. Abrahamsen JF, Andersen A, Hannisdal E, et al: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:235-261, 1993
6. Biti GP, Cimino G, Cartoni C, et al: Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight-year update of an Italian prospective randomized study. J Clin Oncol 10:378-382, 1992
7. Longo DL, Glatstein E, Duffey PL, et al: Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: Seven-year results of a prospective randomized trial. J Clin Oncol 9:906-917, 1991
8. Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 66:977-989, 1982
9. Hancock SL, Cox RS, Rosenberg SA: Correction: Deaths after treatment of Hodgkin's disease. Ann Intern Med 114:810, 1991
10. Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955, 1993
11. Boivin JF, Hutchison GB, Lyden M, et al: Second primary cancers following treatment of Hodgkin's disease. J Natl Cancer Inst 72:233-241, 1984
12. Cimino G, Papa G, Tura S, et al: Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study. J Clin Oncol 9:432-437, 1991
13. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
14. Biti G, Cellai E, Magrini SM, et al: Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121 patients from a single institution. Int J Radiat Oncol Biol Phys 29:25-31, 1994
15. Hancock SL, Hoppe RT, Horning SJ, et al: Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. Ann Intern Med 109:183-189, 1988
16. Doria R, Holford T, Farber LR, et al: Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 13:2016-2022, 1995
17. Prosnitz LR, Farber LR, Fischer JJ, et al: Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease. Radiology 107:187-193, 1973
18. Prosnitz LR, Farber LR, Fischer JJ, et al: Long term remissions with combined modality therapy for advanced Hodgkin's disease. Cancer 37:2826-2833, 1976
19. Prosnitz LR, Farber LR, Kapp DS, et al: Combined modality therapy for advanced Hodgkin's disease: Long-term followup data. Cancer Treat Rep 66:871-879, 1982
20. Prosnitz LR, Farber LR, Kapp DS, et al: Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data. J Clin Oncol 6:603-612, 1988
21. DeVita VT Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-895, 1970
22. Bonadonna G, Zucali R, Monfardini S, et al: Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36:252-259, 1975
23. Kaplan ES, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
24. SAS Institute Inc: SAS Technical Report P-179: Additional SAS/STAT Procedures, Release 6.03. Cary, NC, SAS Institute Inc, 1988
25. Koletsky AJ, Bertino JR, Farber LR, et al: Second neoplasms in patients with Hodgkin's disease following combined modality therapy - The Yale experience. J Clin Oncol 4:311-317, 1986
26. Rosenberg SA: Hodgkin's disease: Challenges for the future. Cancer Res 49:767-769, 1989
27. Henry-Amar M: Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Ann Oncol 4:117-128, 1992
28. Boice JJ: Second cancer after Hodgkin's disease - The price of success? J Natl Cancer Inst 85:4-5, 1993 (editorial)
29. Griem ML, Kleinerman RA, Boice JD Jr, et al: Hodgkin's disease: Study of treatment intensities and incidence of second malignancies. J Natl Cancer Inst 86:842-849, 1994
30. Rodriguez MA, Fuller LM, Zimmerman SO, et al: Hodgkin's disease: Study of treatment intensities and incidences of second malignancies. Ann Oncol 4:125-131, 1993
31. Kaldor JM, Day NE, Bell J, et al: Lung cancer following Hodgkin's disease: A case-control study. Int J Cancer 52:677-681, 1992
32. Boivin JF, Hutchison GB, Lubin JH, et al: Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69:1241-1247, 1992
33. Manch PM, Kalish LA, Chayt Marcus K, et al: Long-term survival in Hodgkin's disease. Relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1:33-42, 1995
34. Donaldson SS: Late effects in Hodgkin's disease. The Stanford experience of 30 years, in American Society of Clinical Oncology - Educational Book. Alexandria, VA, American Society of Clinical Oncology, 1994, pp 106-109
35. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
36. Fabian CJ, Mansfield CM, Dahlberg S, et al: Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study. Ann Intern Med 120:903-912, 1994
37. Connors JM, Klimo P, Fairey RN, et al: Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 107:25-30, 1988
38. Valagussa P: Second neoplasms following treatment of Hodgkin's disease. Curr Opin Oncol 5:805-811, 1993
39. Carde P, Hagenbeek A, Hayat M, et al: Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: The H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 11:2258-2272, 1993
40. Bonadonna G: Modern treatment of malignant lymphomas: A multidisciplinary approach? The Kaplan Memorial Lecture. Ann Oncol 5:5-16, 1994
41. Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 5:742-749, 1987